Manchester Capital Management’s iShares US Medical Devices ETF IHI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$401K Hold
8,110
0.05% 188
2026
Q1
$433K Buy
8,110
+610
+8% +$35.8K 0.06% 181
2025
Q4
$466K Hold
7,500
0.06% 173
2025
Q3
$451K Hold
7,500
0.06% 206
2025
Q2
$470K Hold
7,500
0.06% 217
2025
Q1
$451K Hold
7,500
0.06% 213
2024
Q4
$438K Hold
7,500
0.05% 211
2024
Q3
$444K Hold
7,500
0.05% 214
2024
Q2
$420K Buy
+7,500
New +$420K 0.05% 218

Other funds holding IHI

Manchester Capital Management's IHI Position: Q2 2026 in Review

Manchester Capital Management held its iShares US Medical Devices ETF (IHI) position steady in Q2 2026 at 8,110 shares worth $401K. The position accounts for 0.05% of the portfolio, ranked #188.

Manchester Capital Management first reported a position in IHI in Q2 2024 and has held it in 9 quarters since. The position peaked at $470K in Q2 2025. 503 funds tracked by Wall St. Rank hold IHI as of Q2 2026.

  • Manchester Capital Management held 8,110 shares of iShares US Medical Devices ETF worth $401K as of Q2 2026.
  • Manchester Capital Management left its iShares US Medical Devices ETF share count unchanged in Q2 2026.
  • iShares US Medical Devices ETF made up 0.05% of Manchester Capital Management's portfolio in Q2 2026, its #188 holding.
  • Manchester Capital Management first reported a position in iShares US Medical Devices ETF in Q2 2024 and has held it in 9 quarters since.
  • Manchester Capital Management's iShares US Medical Devices ETF position peaked at $470K in Q2 2025.
  • 503 funds tracked by Wall St. Rank held iShares US Medical Devices ETF as of Q2 2026.

Based on Manchester Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.